Neurobo Pharmaceuticals Appoints Hyung Heon Kim As Chief Executive Officer And President; Mr. Kim Succeeds Joseph Hooker, Who Served As Interim Chief Executive Officer And President Since January 2023
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced the appointment of current Board member, Hyung